RT @KDAO2011: #EULAR2020 Prof. T Domer: baricitinib show promise in phase II trial for SLE: Microarray analysis noted
Tweet Content
#EULAR2020 Prof. T Domer: baricitinib show promise in phase II trial for SLE: Microarray analysis noted reduction in IFN signature; however, the reduction did not correlate w/SLEDAI-2K or SRI4 clinical response @RheumNow https://t.co/cW4egzSnAs
Show on Archive Page
On
Display in Search Results
On